Bob Azopardi Patient Shares His Clinical Trial Experience

Are patients that participate in clinical trials pioneers? Andrew Schorr, Patient Power Founder, interviewed Bob Azopardi, a 16-year CLL patient who participated in the Phase III arm of the venetoclax (Venclexta) clinical trial. Bob discusses his involvement on the trial including the many safety precautions in place for patients and the new quality of life he experiences.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo